GLP1R and pancreatic insulinoma: The 68Ga‐NOTA‐exendin‐4 PET‐CT technique leverages the GLP‐1 receptor agonist exenatide, which is radiolabeled with 68Ga, to visualize an abnormal concentration of radioactivity in the tumor region of patients with insulinoma.